Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
3.720
+0.040 (1.09%)
Nov 22, 2024, 4:00 PM EST - Market closed

Mereo BioPharma Group Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for MREO stock have an average target of 7.50, with a low estimate of 7.00 and a high estimate of 8.00. The average target predicts an increase of 101.61% from the current stock price of 3.72.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $7.00 $7.50 $8.00 $8.00
Change +88.17% +101.61% +115.05% +115.05%

Analyst Ratings

The average analyst rating for MREO stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 111111
Buy 333333
Hold 000000
Sell 000000
Strong Sell 000000
Total 444444

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Needham
Needham
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +88.17% Nov 12, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$7
Buy Reiterates $7 +88.17% Oct 1, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$7
Buy Reiterates $7 +88.17% Sep 16, 2024
Needham
Needham
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +88.17% Aug 13, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$7
Buy Reiterates $7 +88.17% Jul 22, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
11.64M
from 10.00M
Increased by 16.39%
Revenue Next Year
12.74M
from 11.64M
Increased by 9.44%
EPS This Year
-0.02
from -0.22
EPS Next Year
-0.02
from -0.02
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
--36.46M-10.00M11.64M12.74M69.10M
Revenue Growth
-----16.39%9.44%442.44%
EPS
-1.95-2.41-0.23-0.35-0.22-0.02-0.02-0.02
EPS Growth
--------
Forward PE
--------
No. Analysts -----774
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 59.9M 36.8M 148.5M
Avg 11.6M 12.7M 69.1M
Low n/a n/a 1.0M

Revenue Growth

Revenue Growth 20242025202620272028
High
499.1%
215.9%
1,065.4%
Avg
16.4%
9.4%
442.4%
Low - -
-92.0%

EPS Forecast

EPS 20242025202620272028
High 0.05 -0.01 -0.02
Avg -0.02 -0.02 -0.02
Low -0.05 -0.04 -0.02

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.